The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only
Telix Pharmaceuticals (Innovations) Pty Limited
Telix Pharmaceuticals (Innovations) Pty Limited
Bayer
PCI Biotech AS
Myriad Genetic Laboratories, Inc.
Diffusion Pharmaceuticals Inc
Takeda
Nohla Therapeutics, Inc.
Eske Corporation S.A.C
Endo Pharmaceuticals
Dendreon
Sotio Biotech Inc.
Hoffmann-La Roche
Hoffmann-La Roche
Merck KGaA, Darmstadt, Germany
Endo Pharmaceuticals